Home > Boards > US Listed > Biotechs > Seattle Genetics (SGEN)

*****Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TREND1 Member Profile
Member Level 
Followed By 407
Posts 54,200
Boards Moderated 33
Alias Born 12/16/01
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 1:38:19 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 12:11:05 PM
Seattle Genetics Announces FDA Filing Acceptance for Priority Review of Tucatinib New Drug Application (NDA) for Patients wit... Business Wire - 2/13/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/12/2020 5:39:52 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 2:53:27 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 11:15:05 AM
Seattle Genetics & Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV™ (enfortumab vedotin-ejfv) in Combinat... Business Wire - 2/11/2020 8:00:00 AM
Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV™ (enfortumab vedotin-ejfv) in Combin... PR Newswire (US) - 2/10/2020 5:00:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/7/2020 8:46:46 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/6/2020 5:19:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/6/2020 4:11:25 PM
Seattle Genetics Reports Fourth Quarter and Full Year 2019 Financial Results Business Wire - 2/6/2020 4:02:00 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 2/6/2020 12:54:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/5/2020 6:08:55 PM
EMA Validates Seattle Genetics’ Marketing Authorization Application for Tucatinib for Patients with Locally Advanced or Met... Business Wire - 1/31/2020 8:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 1/28/2020 9:11:39 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 1/28/2020 9:10:31 AM
Schedule 13g Edgar (US Regulatory) - 1/27/2020 3:57:34 PM
Seattle Genetics to Host Conference Call & Webcast Discussion of Fourth Quarter & Full Year 2019 Financial Results on Februar... Business Wire - 1/21/2020 8:30:00 AM
Seattle Genetics Achieves Milestone Following European Commission Approval of Roche’s Polivy® (Polatuzumab Vedotin) Business Wire - 1/21/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/16/2020 4:56:53 PM
Seattle Genetics to Present at the J.P. Morgan Healthcare Conference Business Wire - 1/6/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/23/2019 5:28:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/23/2019 5:24:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/23/2019 5:23:24 PM
TREND1 Member Level  Saturday, 07/16/16 03:28:06 PM
Re: None
Post # of 254 
*****Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its second quarter 2016 financial results on Tuesday, July 26 after the close of financial markets. Following the results announcement, company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows:

LIVE access on Tuesday, July 26, 2016

1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time
• Telephone 888-576-4398 (domestic) or 719-325-2329 (international); conference ID 2574870
• Webcast available at www.seattlegenetics.com in the Investors and News section

REPLAY access
• Telephone replay will be available beginning at approximately 4:30 p.m. PT on Tuesday, July 26, 2016 through 5:00 p.m. PT on Friday, July 29, 2016 by calling 888-203-1112 (domestic) or 719-457-0820 (international); conference ID 2574870
• Webcast replay will be available on the Seattle Genetics website at www.seattlegenetics.com in the Investors and News section


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist